tiprankstipranks
Trending News
More News >
Vivos Therapeutics’ Earnings Call Highlights Growth and Expansion
PremiumCompany AnnouncementsVivos Therapeutics’ Earnings Call Highlights Growth and Expansion
2M ago
Vivos Therapeutics price target lowered to $5.50 from $6 at Alliance Global Partners
Premium
The Fly
Vivos Therapeutics price target lowered to $5.50 from $6 at Alliance Global Partners
2M ago
Vivos Therapeutics Reports Revenue Growth and Strategic Shift
Premium
Company Announcements
Vivos Therapeutics Reports Revenue Growth and Strategic Shift
2M ago
Vivos Therapeutics files to sell 854,332 shares of common stock for holders
PremiumThe FlyVivos Therapeutics files to sell 854,332 shares of common stock for holders
5M ago
Morning Movers: Despegar surges following deal to be acquired by Prosus
Premium
The Fly
Morning Movers: Despegar surges following deal to be acquired by Prosus
6M ago
Vivos to sell 709,220 shares at $4.935 in registered direct offering
Premium
The Fly
Vivos to sell 709,220 shares at $4.935 in registered direct offering
6M ago
Morning Movers: Darden rises following first quarter results
PremiumThe FlyMorning Movers: Darden rises following first quarter results
9M ago
Vivos Therapeutics prices $4.3M registered direct offering at $3.15 per share
Premium
The Fly
Vivos Therapeutics prices $4.3M registered direct offering at $3.15 per share
9M ago
Vivos Therapeutics prices 1.36M shares at $3.15 in registered direct offering
Premium
The Fly
Vivos Therapeutics prices 1.36M shares at $3.15 in registered direct offering
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100